Embed Notice

Gilead Shot Prevents All HIV Cases in Trial of African Women

Gilead Sciences Inc.’s experimental twice-yearly shot prevented 100% of HIV cases in women and adolescent girls in Africa, the first successful big trial of what’s hoped to become a powerful new drug regimen for fending off the virus.

Lenacapavir will provide an easier-to-use option compared to other HIV prevention drugs that are either daily pills or must be injected every two months. https://www.msn.com/en-us/health/other/gilead-shot-prevents-all-hiv-cases-in-trial-of-african-women/ar-BB1oAfz8